Lixte Biotechnology Faces Delisting Notice
Ticker: LIXT · Form: 8-K · Filed: Aug 23, 2024 · CIK: 1335105
| Field | Detail |
|---|---|
| Company | Lixte Biotechnology Holdings, INC. (LIXT) |
| Form Type | 8-K |
| Filed Date | Aug 23, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2,500,000 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: LIXT
TL;DR
LIXT got a delisting warning, trading might get messy.
AI Summary
Lixte Biotechnology Holdings, Inc. filed an 8-K on August 23, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, effective August 19, 2024. The company's principal executive offices are located at 680 East Colorado Boulevard, Suite 180, Pasadena, California.
Why It Matters
This filing indicates potential delisting from a stock exchange, which could significantly impact the liquidity and trading of Lixte Biotechnology's shares.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Filer of the 8-K report
- August 19, 2024 (date) — Date of earliest event reported (delisting notice)
- August 23, 2024 (date) — Date the 8-K was filed
- 680 East Colorado Boulevard , Suite 180 Pasadena , California 91101 (address) — Principal executive offices of Lixte Biotechnology Holdings, Inc.
FAQ
What specific listing rule or standard has Lixte Biotechnology Holdings, Inc. failed to satisfy?
The filing states that Lixte Biotechnology Holdings, Inc. received a notice of delisting or failure to satisfy a continued listing rule or standard, but does not specify which rule was violated.
When did the notice of delisting become effective?
The notice of delisting or failure to satisfy a continued listing rule or standard was effective as of August 19, 2024.
What is the IRS Employer Identification Number for Lixte Biotechnology Holdings, Inc.?
The IRS Employer Identification Number for Lixte Biotechnology Holdings, Inc. is 20-2903526.
What is the Commission File Number for Lixte Biotechnology Holdings, Inc.?
The Commission File Number for Lixte Biotechnology Holdings, Inc. is 001-39717.
What is the telephone number for Lixte Biotechnology Holdings, Inc.'s principal executive offices?
The telephone number for Lixte Biotechnology Holdings, Inc.'s principal executive offices is (631) 830-7092.
Filing Stats: 591 words · 2 min read · ~2 pages · Grade level 14.4 · Accepted 2024-08-23 16:05:31
Key Financial Figures
- $2,500,000 — es the Company to maintain a minimum of $2,500,000 in stockholders' equity for continued l
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001493152-24-033705.txt ( ) — 244KB
- lixt-20240819.xsd (EX-101.SCH) — 3KB
- lixt-20240819_def.xml (EX-101.DEF) — 26KB
- lixt-20240819_lab.xml (EX-101.LAB) — 36KB
- lixt-20240819_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 23, 2024 LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Registrant) By: /s/ BASTIAAN VAN DER BAAN Bastiaan van der Baan Chief Executive Officer